Cargando…
Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
BACKGROUND: The main purpose of this study is to compare the vitreous hemorrhage (VH) score reduction and visual acuity outcomes in patients with VH secondary to proliferative diabetic retinopathy (PDR) treated with intravitreal injections of bevacizumab (IVB) versus IVB and pars plana vitrectomy (I...
Autores principales: | Jorge, Danilo Moyses, Tavares Neto, José Edísio da Silva, Poli-Neto, Omero Benedicto, Scott, Ingrid U., Jorge, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074210/ https://www.ncbi.nlm.nih.gov/pubmed/33902755 http://dx.doi.org/10.1186/s40942-021-00296-7 |
Ejemplares similares
-
Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview
por: Faisal, Syed Muhammad, et al.
Publicado: (2018) -
Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
por: Zaman, Yawar, et al.
Publicado: (2013) -
Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013) -
Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2023) -
Endophthalmitis following pars plana vitrectomy for vitreous floaters
por: Henry, Christopher R, et al.
Publicado: (2014)